Navigation Links
UAlberta researchers uncover why combination drug treatment ineffective in cancer clinical trials
Date:12/5/2013

Medical researchers at the University of Alberta have discovered that combination drug therapy didn't work well in clinical trials for cancer patients because one drug was making the other drug ineffective.

Faculty of Medicine & Dentistry researcher Michael Sawyer and his colleagues, including first author Vijaya Damaraju, recently published their findings in the peer-reviewed journal, Clinical Cancer Research.

In the '80s and '90s, cancer research focused on finding out which proteins "drove" cancers. New drugs targeting these proteins worked well by themselves, and some in the field believed combining the new drugs with the older chemotherapy drugs would work better than either drug by itself.

"So the pharmaceutical industry developed a combination of drugs in which we thought we were giving two drugs at once, but in actual fact the one drug we were giving was completely blocking the actions of the other drug," said Sawyer, who works in the Faculty's Department of Oncology.

"The old chemotherapy drugs required special proteins to get inside of cells to work. What our team discovered is that the new chemotherapy drugs prevented these proteins from carrying the old chemotherapy drugs into the cell. No one was able to figure out why this combination of drugs didn't work, but now we have discovered what went wrong." Sawyer says the findings will guide oncologists about how cancer drugs should be combined, or whether certain drugs should be combined at all.

"This will save us from doing millions of dollars in clinical trials that have no chance of working out. These findings show oncologists we have to be careful about which drugs should be combined. You have to think about how they actually work, especially in ways which no one understood before.

"Our research was actually like peeling an onion. Once we figured out the answer to one question, then other things the drugs did make more sense. Ultimately, the findings mean we'll be able to design better combination drug therapies. We'll know which drugs to combine, and when and how drugs can be combined. This will require more precise scheduling and dosing than what we've done to date."

He stressed the only patients impacted were those in clinical trials the combination drug therapy had not yet become common clinical practice because it wasn't working the way oncologists had hoped. And for those patients who took part in the clinical trials, the one chemotherapy drug was still very effective so those patients still received excellent care and drugs that properly targeted their cancers.

Sawyer and his team are continuing their research in this area. Their research was funded by the former Alberta Cancer Board, the Alberta Cancer Foundation and Alberta Innovates Health Solutions.


'/>"/>

Contact: Raquel Maurier
rmaurier@ualberta.ca
780-492-5986
University of Alberta Faculty of Medicine & Dentistry
Source:Eurekalert

Related medicine news :

1. UAlberta prostate cancer researcher and team developing homing beacon drugs to target cancer cells
2. UAlberta medical researchers make key discovery in fight against Alzheimers disease
3. UAlberta medical researchers discover new potential chemotherapy
4. Alternative medicine use high amoung children with chronic conditions: UAlberta medical research
5. Alternative medicine use high among children with chronic conditions: UAlberta medical research
6. New UAlberta research shows commonly prescribed medications could have adverse effects
7. UAlberta researcher pinpoints prescription for successful Primary Care Networks
8. Low birth weight could be a risk factor for age-related vision loss: UAlberta medical research
9. Music decreases perceived pain for kids in pediatric ER: UAlberta medical research
10. NIH awards $20 million over 5 years to train next generation of global health researchers
11. Researchers develop a new cell and animal model of inflammatory breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... 22, 2017 , ... Pullano Law Offices, a Chicago personal injury law firm, ... selected to serve as President of the North Suburban Bar Association for 2017-2018. Mr. ... hosted by the NSBA at the North Shore Country Club in Glenview, IL, on ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... Rob Lowe, explores the world of Alzheimer’s. Alzheimer’s is a disease estimated to ... This according to information published by the Alzheimer’s Association, a leading voice in ...
(Date:9/22/2017)... ... September 22, 2017 , ... The freshly ... customers’ doorstep. According to Smart Mart, customers can now order vegetable, fruit, snacks, ... and customers can find clothing at discounted prices. Apart from this, Smart Mart ...
(Date:9/21/2017)... , ... September 21, 2017 , ... 38-Year-Old Plastic Surgeon ... Center in Naples, Florida is pleased to announce that Plastic Surgeon Kiranjeet Gill has ... 40 Under 40 is an annual award that was started in 2003 to ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... ... **An FDAnews Management Report**, http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of ... can get while staying in compliance with FDA rules. , The FDA has ...
Breaking Medicine News(10 mins):
(Date:9/13/2017)... 13, 2017   OrthoAtlanta has been named the ... Host Committee (AFHC) for the 2018 College Football Playoff (CFP) ... at Mercedes-Benz Stadium in Atlanta, Georgia . ... "I,m In" campaign, participating in many activities leading up to, ... ...
(Date:9/12/2017)... N.J. , Sept. 12, 2017  Consumer reviews on the ... Hearing as the number one company for hearing aids, ranking ... and fifteen other brands. ... Embrace Hearing Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that provides high ...
(Date:9/9/2017)... 8, 2017 ... Unit coming to Washington DC ... When: Tuesday, September 12 th – Monday, September 18 th .The ... free MRI brain scans to the public.Where:  BTF,s ... at 501 K Street NW, Washington, D.C.What:BTF brings its nationwide initiative, the ...
Breaking Medicine Technology: